跳至主要内容
临床试验/ISRCTN16600471
ISRCTN16600471已完成未知

The impact of a fat-rich preload before a carbohydrate-rich meal on glucose homeostasis in patients without diabetes after sleeve gastrectomy: a proof-of-concept, randomized, open-label, crossover study

niversity of Leicester0 个研究点目标入组 10 人开始时间: 2021年3月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged =18 years old
  • 2. =1 year after sleeve gastrectomy (SG)
  • 3. Able to understand written and spoken English
  • 4. Able to give informed consent
  • 5. Happy for their GP to be notified of their study participation

排除标准

  • 1. Use of any glucose-lowering medication (including insulin)
  • 2. Adrenal insufficiency and/or substitution with glucocorticoids
  • 3. eGFR =45 ml/min/1.73 m²
  • 4. Weight =50 kg
  • 5. Recent active infection (an active infection will be any infection over the last 10 days)
  • 6. Current use of steroids
  • 7. Known liver cirrhosis or ALT >2 times above the upper normal limit
  • 8. People with allergy or intolerance to the mixed meal tolerance test (e.g., milk protein allergy, lactose and gluten intolerance), to paracetamol or to nuts
  • 9. People who are on regular painkillers (codeine phosphate, paracetamol, morphine or NSAIDS)
  • 10. Other bariatric procedure except for SG
  • 11. Previous revisional bariatric surgery
  • 12. Hb <100 g/l at screening blood tests
  • 13. HbA1C =6.5% or =48 mmol/l at screening blood tests
  • 14. Currently pregnant or breastfeeding
  • 15. Patients with a history of type 1 or type 2 diabetes
  • 16. Patients with a diagnosis of epilepsy
  • 17. Participating in another research study involving intervention within 3 months of screening
  • 18. Having a formal previous diagnosis of postprandial hypoglycaemia
  • 19. Currently on metoclopramide, domperidone or colestyramine as they can affect paracetamol absorption as per SPC (Summary of Product Characteristics) for paracetamol
  • 20. Currently on acarbose, diazoxide, octreotide or other treatment for postprandial hypoglycaemia
  • 21. Any concurrent condition, in the judgment of investigator and/or sponsor, that could interfere with the safety and study conduct or interpretation of study results

研究者

发起方
niversity of Leicester

相似试验